 Connection
Andrea Steck to Treatment Outcome
This is a "connection" page, showing publications Andrea Steck has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.039 |
|
|
|
-
Karakus KE, Chesshir L, Walker S, Baschal EE, McDaniel KA, Triolo TM, Steck AK, Frohnert BI, Gottlieb PA, Michels AW, Simmons KM. Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes. Diabetologia. 2026 May; 69(5):1164-1175.
Score: 0.021
-
Poppy A, Retamal-Munoz C, Cree-Green M, Wood C, Davis S, Clements SA, Majidi S, Steck AK, Alonso GT, Chambers C, Rewers A. Reduction of Insulin Related Preventable Severe Hypoglycemic Events in Hospitalized Children. Pediatrics. 2016 07; 138(1).
Score: 0.011
-
Urwyler SA, Schuetz P, Fluri F, Morgenthaler NG, Zweifel C, Bergmann A, Bingisser R, Kappos L, Steck A, Engelter S, Müller B, Christ-Crain M, Katan M. Prognostic value of copeptin: one-year outcome in patients with acute stroke. Stroke. 2010 Jul; 41(7):1564-7.
Score: 0.007
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|